Issue 1386: September 26, 2018


TOP STORIES


IAC HANDOUTS


WORLD NEWS


FEATURED RESOURCES


EDUCATION AND TRAINING


CONFERENCES AND MEETINGS

 


TOP STORIES


Plotkin's Vaccines textbook wins first prize in public health category for the 2018 British Medical Association’s Medical Book Award

On September 4, the seventh edition of the authoritative immunization textbook, Plotkin's Vaccines, won first prize in the public health category at the British Medical Association Awards. Portions of the Elsevier press release are reprinted below.

Elsevier, the global information analytics business specializing in science and health, and its authors had a strong showing at the British Medical Association’s (BMA) annual BMA Medical Book Awards ceremony, winning nine of the 20 categories.

Out of 670 titles submitted to the BMA from publishers around the globe, a total of 41 Elsevier professional and scholarly products were honored, including nine first prizes and 32 Highly Commended recognitions....

Dr. Stanley Plotkin, Emeritus Professor of Pediatrics, University of Pennsylvania, and former Chief, Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, PA, whose book
Plotkin's Vaccines, 7th Edition won First Prize in the Public Health category, said, “The progress of vaccine development and use has dramatically increased since the first edition of Vaccines in 1988. The 7th Edition reflects this progress, which is providing protection against numerous deadly pathogens. Vaccinology is now a domain of medicine in its own right.”  



Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin's Vaccines is a must-have reference for current, authoritative information in this fast-moving field. The authors are Stanley A. Plotkin, MD; Walter Orenstein, MD, DSc (HON); Paul A. Offit, MD, and Kathryn M. Edwards, MD.

Access additional information from Elsevier about the book, including the table of contents and ordering information.

Back to top


The immunization community mourns our loss of Lynn Bozof, president and cofounder of the National Meningitis Association

IAC joins the entire immunization community in mourning the loss of Lynn Bozof, president and cofounder of the National Meningitis Association. Following the death of her son Evan at age 20 from meningococcal meningitis, Lynn became a tireless advocate for the use of meningococcal vaccines, working to make sure all parents were aware of their existence and their availability for children and teens. Lynn frequently attended meetings of the Advisory Committee on Immunization Practices (ACIP) in Atlanta to give public testimony, urging the committee to expand its recommendations for broader use of meningococcal vaccines. Lynn’s selfless commitment won her national recognition as a true champion for protecting lives through vaccination.

The National Meningitis Association released the following statement about Lynn’s passing:

It is with profound sadness that the National Meningitis Association announces the death of our President, Lynn Bozof. Lynn, who lost her son Evan to meningococcal meningitis, founded NMA with four other parents 16 years ago.  Lynn died of pancreatic cancer on September 15 surrounded by her family. 
 
“Lynn was passionate about NMA’s mission to protect our children through meningococcal and other vaccines,” said Leslie Maier, Secretary/Treasurer of NMA.  According to NMA Director Lori Buher, “Lynn worked tirelessly for NMA until just weeks before her death. She left NMA in a strong place and our Board and national network of advocates will continue to advance NMA and its mission in Lynn’s memory.

“We send our deepest condolences to Lynn’s husband, Alan, who was always by her side; to her son, Ryan; and her daughter-in-law, Shadi; and her three grandchildren, who were the light of her life. Our hearts also go out to Lynn’s sister, Sue Greene, who has become an important voice in the meningitis prevention community.”


Condolence cards can be sent to the following address: 

National Meningitis Association 
P.O. Box 60143 
Ft. Myers, FL 33906

Related Links

Back to top


Annual NFID influenza and pneumococcal news conference will be held on September 27; listen to the event and join the Twitterstorm

The annual National Foundation for Infectious Diseases (NFID) Influenza and Pneumococcal Vaccination Kick-Off news conference will be held in Washington, DC, on September 27 at 10:00 a.m. (ET). At the event, a panel of experts will engage in discussions about the previous and upcoming flu seasons. To listen to this 1-hour press conference live, you must pre-register.

In addition, CDC and NFID are hosting a #FightFlu Twitterstorm on the same day between 10:00 a.m. and 2:00 p.m. (ET). Tweet messages about flu prevention and why you choose to vaccinate using the hashtag #FightFlu. Retweet messages posted by your peers: @CDCflu and @NFIDvaccines



Back to top
 


IAC Spotlight: IAC’s recently updated Adult Vaccination web page is full of resources to help you vaccinate adults this fall and beyond

Recently updated, IAC's Adult Vaccination web page on immunize.org is full of resources from IAC and its partner organizations to help you vaccinate adults this fall or any time! This web page is easy to find from anywhere on immunize.org. From the row of blue tabs across the top of every immunize.org web page, select the "Clinic Tools" tab (third from the left). Then select "Adult Vaccination" from the drop-down menu.

In the left-hand column of the page, you will find IAC's educational tools related to adult immunization, including handouts for healthcare professionals and for patients, standing orders templates, and a link to all IAC Adult Vaccination education materials

In addition, in the right-hand column of the web page, you will find links to adult vaccination resources from IAC's partner organizations, including CDC, American College of Physicians, American College of Obstetricians and Gynecologists, American Academy of Family Physicians, National Adult and Influenza Immunization Summit, National Vaccine Program Office, and National Foundation for Infectious Diseases.

In both columns, you will find prominent display boxes that link to IAC's 142-page book, Vaccinating Adults: A Step-by-Step Guide.

Find all the resources and tools you need for adult immunization by visiting IAC's Adult Vaccination web page at www.immunize.org/adult-vaccination today!

Related Link

Back to top


CDC issues clinical guidance for providers during the Shingrix vaccine shortage

In light of the current shortage of recombinant zoster vaccine (Shingrix; GSK), CDC has prepared a statement for healthcare providers reminding them about considerations and the importance of the 2nd dose. The statement is reprinted below.
 
There are currently ordering limits and intermittent shipping delays for GlaxoSmithKline’s Shingrix vaccine (recombinant zoster vaccine) due to high demand. Until demand can be met, it is particularly important that vaccine providers educate patients about the importance of completing the series. In addition, CDC reminds healthcare professionals of proven strategies to help patients receive all their needed vaccinations on time, including Shingrix: 

  • Implement a vaccine reminder and recall system using phone, e-mail, or text messages to contact patients when you have Shingrix supply. Give first consideration to patients due for their second dose of Shingrix (https://www.thecommunityguide.org/findings/vaccination-programs-client-reminder-and-recall-systems).
  • If you are out of Shingrix and a patient needs a second dose, refer the patient to another provider in the community (e.g., a pharmacy) that has Shingrix so the patient can complete the series. The immunization program at your state or local health department or vaccine finder can help identify other immunization providers (https://vaccinefinder.org).
  • Be sure to enter your patients’ current vaccination information into your state’s immunization information system (IIS). This will ensure that every provider can access your patients’ immunization record, and it may help facilitate patient reminders to complete the Shingrix series.
  • As supply becomes less constrained, be sure to notify eligible patients so they can come in to get their first dose of Shingrix. 

Timely series completion is key to the success of any vaccination program and critical to ensuring patients receive the full benefit of their vaccinations.

Related Links

Back to top


CDC issues bulletin on tetanus in areas affected by a hurricane, including clinical guidance for providers

CDC issued Tetanus in Areas Affected by a Hurricane: Risk, Prevention, and Management Guidance for Clinicians in the September 21 issue of Clinician Outreach and Communication Activity (COCA) Now. Portions of the bulletin are reprinted below.
 
Exposure to flood waters does not increase the risk of tetanus, so tetanus immunization campaigns are not needed for evacuees from flooding disasters. However, during evacuation and flood cleanup, emergency responders, cleanup workers, volunteers, and residents may be at increased risk for wounds, such as puncture to the skin, cuts, bruises, lacerations, scrapes, or other skin injuries that become contaminated with flood waters, human or animal waste, soil, dirt, or saliva. These workers and residents should make sure they are up-to-date with tetanus vaccination before starting cleanup activities....

Tetanus is a medical emergency requiring hospitalization, immediate treatment with human tetanus immune globulin (TIG), agents to control muscle spasm, aggressive wound care, antibiotics, and a tetanus toxoid booster....


Related Links

Back to top


IAC updates two of its popular Ask the Experts sections: one on diphtheria, pertussis, and tetanus and the second on Hib vaccines

IAC's Ask the Experts: Diphtheria, Tetanus, Pertussis and Ask the Experts: Haemophilus influenzae type b (Hib) web pages have been completely reviewed and updated by experts at CDC.

Ask the Experts: Diphtheria, Tetanus, Pertussis: Revisions include the elimination of temperature of 105 degrees F as a precaution to receiving DTaP vaccine; these changes are consistent with Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the recently revised DTaP Vaccine Information Statement.

Ask the Experts: Haemophilus influenzae type b (Hib): Revisions include the removal of a reference to products that are no longer distributed in the United States (e.g. Menhibrix), update of several URLs and references, and minor editorial revisions.

IAC’s Ask the Experts web section is a compilation of common as well as challenging questions and answers (Q&As) about vaccines and their administration. William Atkinson, MD, MPH, IAC's associate director for immunization education, manages this web section, with answers provided by Andrew T. Kroger, MD, MPH; Candice L. Robinson, MD, MPH; Raymond A. Strikas, MD, MPH, FACP, FIDSA; Tina S. Objio, MSN, MHA, RN; and JoEllen Wolicki, BSN, RN, all from the National Center for Immunization and Respiratory Diseases, CDC.

IAC Express publishes five special editions each year of Ask the Experts Q&As answered by CDC experts. You can access the four most recent IAC Express Ask the Experts sets of Q&As from the main web page of Ask the Experts, in the right-hand column.

Related Links

Back to top


Three healthcare organizations join IAC's Influenza Vaccination Honor Roll for mandatory healthcare worker vaccination; 681 now enrolled

There are now 681 organizations enrolled in IAC's Influenza Vaccination Honor Roll. The honor roll recognizes hospitals, medical practices, professional organizations, health departments, and government entities that have taken a stand for patient safety by implementing mandatory influenza vaccination policies for healthcare personnel.

Since August 15, when IAC Express last reported on the Influenza Vaccination Honor Roll, six additional healthcare organizations have been enrolled.

IAC urges qualifying healthcare organizations to apply.

Newly added healthcare organizations, hospitals, government agencies, and medical practices

  • Maricopa Integrated Health System, Phoenix, AZ
  • Bloomingdale Medical Associates, Riverview, FL
  • Providence St. Joseph Medical Center, Polson, MT

Related Links

Back to top


Beware of B campaign urges Big Ten universities to require the meningitis B vaccination for incoming students; Indiana University and Purdue University on board

Beware of B is a national campaign to encourage Big Ten universities to require the meningitis B vaccination for incoming students. The campaign encourages you to take two minutes to watch this powerful video that brings to life the devastation of meningitis and the importance of getting vaccinated.  

Since 2011, 100 percent of the college outbreaks of meningitis have been the B strain. Due to the close quarters and conditions of coed life, college campuses continue to be a breeding ground for meningitis B. It is important that we come together to implore universities to take the necessary steps to protect their students.  

Big Ten universities Purdue University and Indiana University announced this spring that they require the meningitis B vaccination for all students. 

Beware of B has joined fellow health organizations around the country in a campaign to protect youth from this deadly disease. Help to raise awareness and encourage Big Ten universities, and all universities to #BewareofB. 

Back to top


IAC HANDOUTS


IAC makes correction to newly updated standing orders template for influenza vaccination of children/teens

IAC recently revised Standing Orders for Administering Influenza Vaccine to Children and Teens to correct an age range in the instructions for administering influenza vaccine to children age 6 through 35 months. The text now reads: "...children age 12 through 35 months may receive injection in the deltoid muscle." 

Related Links

Back to top


WORLD NEWS


WHO reports on cholera and poliomyelitis in this week's Weekly Epidemiological Record

The World Health Organization (WHO) published Cholera, 2017, and Performance of acute flaccid paralysis (AFP) surveillance and incidence of poliomyelitis, 2018, in the September 21 issue of its Weekly Epidemiological Record. A section of the cholera report is reprinted below.

The year 2017 was historic for cholera in several ways: it marked 200 years since the onset of the first recognized cholera pandemic in 1817, while the current seventh pandemic continues as the longest ever recorded. Explosive, country-wide epidemics of cholera killed thousands of people in Yemen (2261), the Democratic Republic of the Congo (DRC) (1190) and Somalia (1007). Yemen was the first country on record to report more than one million suspected cases in a single year, while DRC (56 190) and Somalia (75 414) approached the highest numbers of cases in their recent history.... 

Related Link

Back to top
 


FEATURED RESOURCES


Still available! IAC's sturdy laminated version of the 2018 U.S. adult immunization schedule—order a supply for your healthcare setting today! Child/teen schedules sold out.

IAC's laminated versions of the 2018 U.S. adult immunization schedule are covered with a tough, washable coating; they will stand up to a year's worth of use in every area of your healthcare setting where immunizations are given. The schedule is eight pages (i.e., four double-sided pages) and is folded to measure 8.5" x 11". 

The child/teen immunization schedules are sold out. If you wish to order a quantity of 500 or more, you can email admininfo@immunize.org to request a quote.                   

Adult Laminated Immunization Schedules

Laminated schedules are printed in color for easy reading, come complete with essential tables and footnotes, and include contraindications and precautions—a feature that will help you make an on-the-spot determination about the safety of vaccinating patients of any age.

PRICING
1–4 copies: $7.50 each
5–19 copies: $5.50 each
20–99 copies: $4.50 each
100–499 copies: $4.00 each
500–999 copies: $3.50 each

For quotes on customizing or placing orders for 1,000 copies or more, call (651) 647-9009 or email admininfo@immunize.org.

You can access specific information on both schedules, view images of both, order online, or download an order form at the Shop IAC: Laminated Schedules web page.

Back to top


IAC's 142-page book, Vaccinating Adults: A Step-by-Step Guide, describes how to implement adult vaccination services in your healthcare setting and provides a review for staff who already vaccinate adults; IAC Guide available for free download

In late 2017, the Immunization Action Coalition (IAC) announced the publication of its new book, Vaccinating Adults: A Step-by-Step Guide (Guide).



This completely updated guide on adult immunization (originally published in 2004) provides easy-to-use, practical information covering important “how-to” activities to help providers enhance their existing adult immunization services or introduce them into any clinical setting, including:

  • setting up for vaccination services,
  • storing and handling vaccines,
  • deciding which people should receive which vaccines,
  • administering vaccines,
  • documenting vaccinations (including legal issues), and
  • understanding financial considerations and billing information.

In addition, the Guide is filled with hundreds of web addresses and references to help providers stay up to date on the latest immunization information, both now and in the future.

The entire Guide is available to download/print free of charge at www.immunize.org/guide. The downloaded version is suitable for double-sided printing. Options are available online to download the entire book or selected chapters. The development of the Guide was supported by the National Vaccine Program Office (NVPO) and the Centers for Disease Control and Prevention (CDC). Expert staff from both agencies also provided early technical review of the content.

The Guide is a uniquely valuable resource to assist providers in increasing adult immunization rates. Be sure to get a copy today!

Related Links

Back to top
 


EDUCATION AND TRAINING


CDC webinar, “2018–2019 Recommendations for Influenza Prevention and Treatment in Children: An Update for Pediatric Providers,” scheduled for September 27
 
CDC will present a one-hour webinar, 2018–2019 Recommendations for Influenza Prevention and Treatment in Children: An Update for Pediatric Providers, beginning at 2:00 p.m. (ET) on September 27. Part of its Clinician Outreach and Communication Activity (COCA) series, the webinar will feature subject matter experts from the American Academy of Pediatrics (AAP) and CDC. Presenters will discuss strategies primary care providers and medical subspecialists can use to improve flu prevention and control in children for the 2018–2019 season. The presenters will share AAP and CDC recommendations about influenza vaccination and antiviral treatment, including updated recommendations for the use of intranasal live attenuated influenza vaccine (LAIV4) in children.

Free continuing education credits (CME, CNE, CEU, CECH, and CPE) will be available. 

Related Link

Back to top


Draft agenda for October ACIP meeting now available

ACIP will hold its next meeting on October 24–25 in Atlanta. The draft agenda is now available online. To attend the meeting, ACIP attendees (participants and visitors) must register online. The registration deadline for non-U.S. citizens is September 26; for U.S. citizens, it's October 10. Registration is not required to watch the meeting via webcast or listen to the proceedings via phone. See the first link below for the toll-free phone number and passcode.

Related Links

Back to top

About IAC Express
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue.

If you have trouble receiving or displaying IAC Express messages, visit our online help section.

IAC Express is supported in part by Grant No. 6NH23IP922550 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC. IAC Express is also supported by educational grants from the following companies: AstraZeneca, Inc.; Merck Sharp & Dohme Corp.; Pfizer, Inc.; and Sanofi Pasteur.

IAC Express Disclaimer
ISSN: 1526-1786
Our mailing address is
Immunization Action Coalition
2550 University Avenue West, Suite 415 North
Saint Paul, MN 55114

Copyright (C) 2018 Immunization Action Coalition
All rights reserved.

About IZ Express

IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .